Your browser doesn't support javascript.
Post coronavirus disease 2019 condition in children at a children's hospital in Japan.
Horikoshi, Yuho; Shibata, Meiwa; Funakoshi, Hanako; Baba, Shintaro; Miyama, Sahoko.
  • Horikoshi Y; Division of Infectious Diseases, Department of Pediatrics, Tokyo Metropolitan Children's Medical Center, Fuchu, Japan.
  • Shibata M; Division of Infectious Diseases, Department of Pediatrics, Tokyo Metropolitan Children's Medical Center, Fuchu, Japan.
  • Funakoshi H; Division of Infectious Diseases, Department of Pediatrics, Tokyo Metropolitan Children's Medical Center, Fuchu, Japan.
  • Baba S; Division of Otorhinolaryngology, Tokyo Metropolitan Children's Medical Center, Fuchu, Japan.
  • Miyama S; Division of Neurology, Tokyo Metropolitan Children's Medical Center, Fuchu, Japan.
Pediatr Int ; 65(1): e15458, 2023 Jan.
Article in English | MEDLINE | ID: covidwho-2193157
ABSTRACT

BACKGROUND:

Acute coronavirus disease 2019 (COVID-19) is associated with chronic symptoms. These have been termed the "post COVID-19 condition." The data on this condition in children are still limited. We therefore aimed to elucidate the characteristics of this post COVID-19 condition.

METHODS:

Children referred to a long COVID-19 clinic were included at Tokyo Metropolitan Children's Medical Center between October 2021 and July 2022. Children with another diagnosis and those who failed to meet criteria for post COVID-19 condition were excluded. Demographic and clinical data were collected retrospectively.

RESULTS:

Of 33 referrals, nine were excluded, and 24 fulfilled the criteria for post COVID-19 condition. The median age and percentage of girls were 12.5 (IQR 11-13) years and 29.2%, respectively. All the patients had mild, acute COVID-19. Dysgeusia and brain fog was observed more frequently during the Delta and Omicron variant periods, respectively. School absenteeism >4 weeks was observed in 41.6% of the patients. Common symptoms included malaise, headache, dysgeusia, and dysosmia. The median duration of post COVID-19 condition was 4.5 (IQR 2.8-5.2) months. Pain management and counseling using the pacing approach were the most commonly offered treatments. Symptom resolution and improvement was observed in 29.2% and 54.2% of the patients, respectively.

CONCLUSIONS:

One third of the patients referred for long COVID did not fit the definition of the post COVID-19 condition. After a median follow up of 4.5 months, the majority of the cases resolved or improved.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Cohort study / Observational study / Prognostic study Topics: Long Covid / Variants Limits: Child / Female / Humans Country/Region as subject: Asia Language: English Journal: Pediatr Int Journal subject: Pediatrics Year: 2023 Document Type: Article Affiliation country: Ped.15458

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Cohort study / Observational study / Prognostic study Topics: Long Covid / Variants Limits: Child / Female / Humans Country/Region as subject: Asia Language: English Journal: Pediatr Int Journal subject: Pediatrics Year: 2023 Document Type: Article Affiliation country: Ped.15458